Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | RTW Investments, LP | 8,705,501 5.200% | -5,002,005 (-36.49%) | Filing History |
| 2025-02-07 06:04 am Purchase | 2025-01-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | BlackRock Inc. BLK | 19,878,746 11.900% | 8,469,528 (+74.23%) | Filing History |
| 2024-11-14 06:48 am Purchase | 2024-09-30 | 13G | ACADIA Pharmaceuticals Inc. ACAD | RTW Investments, LP | 13,707,506 8.300% | 2,453,955 (+21.81%) | Filing History |
| 2024-02-14 07:08 am Purchase | 2023-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | RTW Investments, LP | 11,253,551 6.900% | 11,253,551 (New Position) | Filing History |
| 2024-02-13 4:56 pm Purchase | 2023-12-29 | 13G | ACADIA Pharmaceuticals Inc. ACAD | The Vanguard Group | 13,396,009 8.160% | 116,234 (+0.88%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | ACADIA Pharmaceuticals Inc. ACAD | FMR LLC | 5,265,357 3.207% | -4,069,256 (-43.59%) | Filing History |
| 2024-01-26 5:25 pm Purchase | 2023-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | BlackRock Inc. BLK | 11,409,218 6.900% | 1,150,480 (+11.21%) | Filing History |
| 2023-05-24 5:11 pm Purchase | 2023-05-23 | 13D | ACADIA Pharmaceuticals Inc. ACAD | BAKER BROS. ADVISORS LP | 43,227,599 26.500% | 920,810 (+2.18%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | T. Rowe Price Associates, Inc. | 4,279,254 2.600% | -5,207,007 (-54.89%) | Filing History |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | ACADIA Pharmaceuticals Inc. ACAD | The Vanguard Group | 13,279,775 8.200% | 964,409 (+7.83%) | Filing History |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | ACADIA Pharmaceuticals Inc. ACAD | FMR LLC | 9,334,613 5.764% | -4,506,137 (-32.56%) | Filing History |
| 2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | BlackRock Inc. BLK | 10,258,738 6.300% | 198,426 (+1.97%) | Filing History |
| 2023-01-17 4:32 pm Purchase | 2023-01-12 | 13D | ACADIA Pharmaceuticals Inc. ACAD | BAKER BROS. ADVISORS LP | 42,306,789 26.100% | 1,138,932 (+2.77%) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | T. Rowe Price Associates, Inc. | 9,486,261 5.900% | 1,608,436 (+20.42%) | Filing History |
| 2022-02-09 3:15 pm Purchase | 2021-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | The Vanguard Group | 12,315,366 7.660% | 1,709,593 (+16.12%) | Filing History |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | ACADIA Pharmaceuticals Inc. ACAD | FMR LLC | 13,840,750 8.609% | -5,632,163 (-28.92%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | BlackRock Inc. BLK | 10,060,312 6.300% | 2,302,466 (+29.68%) | Filing History |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | T. Rowe Price Associates, Inc. | 7,877,825 4.900% | -5,363,189 (-40.50%) | Filing History |
| 2021-02-10 10:30 am Sale | 2020-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | The Vanguard Group | 10,605,773 6.670% | -10,840 (-0.10%) | Filing History |
| 2021-02-08 10:15 am Sale | 2021-02-05 | 13G | ACADIA Pharmaceuticals Inc. ACAD | FMR LLC | 19,472,913 12.248% | -1,418,004 (-6.79%) | Filing History |